Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Listed
Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,717 across all filing types
Latest filing 2026-06-21 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590 · 1 venue

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
关于完成董事会换届选举及聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an official announcement from a listed company (古汉医药集团股份公司) regarding the completion of its board of directors' re-election and appointment of senior management personnel and securities affairs representatives. It includes detailed information about the composition of the new board, election dates, roles such as chairman, vice chairman, independent directors, committee members, and senior management appointments like the president, vice presidents, CFO, and board secretary. It also contains biographical summaries of the directors and senior management. The document does not present full financial data or detailed financial analysis. It does not report on earnings, annual reports, or regulatory certifications, but rather focuses on changes in company leadership and governance structure. Therefore, it matches the definition of "Board/Management Information" (MANG), which covers announcements of changes in the company's board of directors or senior management.
2026-06-21 Chinese
第十一届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is an official announcement of the resolutions passed at the first meeting of the eleventh board of directors of the company 古汉医药集团股份公司. It includes detailed voting results for the election and appointment of board members and senior management personnel. It is focused on changes in the company's board and senior management composition. There is no financial data, no annual or interim report contents, no presentation materials, earnings data, or other report content. The content matches the definition of Board/Management Information (MANG), which involves announcements of changes in the company's board of directors or senior management.
2026-06-21 Chinese
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as the "2025年度股东会决议公告" which translates to the "2025 Annual General Meeting (AGM) resolution announcement". It details the resolutions passed at the 2025 Annual General Meeting, including voting results on various proposals such as the 2025 annual report approval, profit distribution, board elections, and other shareholder matters. The document reports the official voting outcomes and confirms the procedural compliance with relevant laws, which matches the definition of "Declaration of Voting Results & Voting Rights Announcements (DVA)". The document length is about 5,601 characters, sufficient to present detailed voting results rather than just a short announcement about a report. It is not the Annual Report itself, but the announcement of shareholder meeting vote results regarding such matters. Therefore, the classification should be DVA with high confidence.
2026-06-17 Chinese
独立董事提名人声明与承诺-雷振华
Board/Management Information Classification · 92% confidence The document is a formal nomination statement and commitment for the independent director candidate (‘雷振华’) by the board of 古汉医药集团股份公司. It outlines board‐level governance and qualification confirmation, but contains no financial data, earnings information, or general regulatory notices. It fits under “Board/Management Information (MANG)” as it announces a board nominee and related declarations.
2026-05-25 Chinese
独立董事提名人声明与承诺-罗怀青
Board/Management Information Classification · 95% confidence The document is a formal nomination statement and undertaking by the company’s board for a candidate to serve as an independent director, detailing qualifications, compliance with regulatory requirements, and board nomination procedures. It does not contain financial statements or report on financial results, nor is it a regulatory announcement about dividend, voting, or capital changes. It clearly pertains to board/management information (appointment/nomination of a director).
2026-05-25 Chinese
古汉医药集团股份公司关于召开2025年度股东会的通知
AGM Information Classification · 89% confidence The document is an official notice by 古汉医药集团股份公司 regarding the convening of its 2025 Annual Shareholders’ Meeting (AGM), including meeting time, venue, agenda items, voting procedures, registration details, and proxy forms. It is neither the meeting minutes nor vote results nor a financial report, but the preparatory materials (meeting notice and related attachments) for the AGM. This matches the definition of “AGM Information” (AGM-R).
2026-05-25 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.